ABSTRACT

Indian pharmaceutical industries export activity has significantly increase after COVID. Since, India's new regulations on medicinal items were implemented, the hike in export intensity has been accompanied by an increase in necessity intensity of Indian pharmaceutical firms. A highly investigated area of international business is analysing the success elements of export performance. In the context of a growing country like India, the major goal of this research article is to identify the factors that influence export performance. Indian pharmaceutical business, which is thought to have great export potential in the years to come, is one of the 50 firms that are taken into consideration in the research. Answer based online quiz is used for data observation, analysis and conclusion. Following a discussion of the required information, a Google Form was created and the questionnaire was distributed by pharmaceutical industrial email Address. The distribution of these 50 participants resulted in a tentative decision of 27 participants. The systematic examination of the data gathered demonstrates that the participants were aware of and knowledgeable about export in certain pharmaceutical industries. its shows that most of Indian pharmaceutical industry adhere to WHO GMP standards, as well as the country's ability to export goods to domestic and foreign markets through its own entity. Examples of these products include pharmaceutical formulations such as tablets, capsules, syrups, and powder, as well as bulk drugs and intermediates. Keywords: WHO-World Health Organization Good manufacturing practice, WTO-World Trade Organization, FTP-Foreign Trade Policy, DGFT-Directorate General Trade of India
Publication date: 01/02/2024

https://ijbpas.com/pdf/2024/February/MS_IJBPAS_2024_7769.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.2.7769